Skip to content
value.today

Corindus Vascular Robotics, Inc.

Formerly Your Internet Defender Inc.

Total raised
$117 M
5 rounds on record
Latest round
$5 M
Mar 2019
First round on record
Sep 2014
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Corindus Vascular Robotics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2019$5 MNo. 5$2 to $10 million

Corindus Vascular Robotics, Inc.: Raise no. 5, Mar 2019

Investors in this round

3 investors had bought by the notice of Mar 21, 2019: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 2 investors are named for Corindus Vascular Robotics, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David W. Long · Executive Officer
  • Douglas R. Teany · Executive Officer
  • Mark J. Toland · Executive Officer, Director
  • Campbell D. Rogers · Director
  • Douglas L. Braunstein · Director
  • James R. Tobin · Director
  • Jeffrey C. Lightcap · Director
  • Jeffrey G. Gold · Director
  • Louis A. Cannon · Director
  • Nathan R. Harrington · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David W. Long, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 21, 2019. Read the notice at the SEC.

equitySEC
Feb 2019$15 MNo. 4$10 to $50 million

Corindus Vascular Robotics, Inc.: Raise no. 4, Feb 2019

Investors in this round

1 investor had bought by the notice of Mar 11, 2019: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 2 investors are named for Corindus Vascular Robotics, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$15 M of $15 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David W. Long · Executive Officer
  • Douglas R. Teany · Executive Officer
  • Mark J. Toland · Executive Officer, Director
  • Campbell D. Rogers · Director
  • Douglas L. Braunstein · Director
  • James R. Tobin · Director
  • Jeffrey C. Lightcap · Director
  • Jeffrey G. Gold · Director
  • Louis A. Cannon · Director
  • Nathan R. Harrington · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David W. Long, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 11, 2019. Read the notice at the SEC.

equitySEC
Mar 2018$25 MNo. 3$10 to $50 million

Corindus Vascular Robotics, Inc.: Raise no. 3, Mar 2018

Investors in this round

4 investors had bought by the notice of Mar 28, 2018: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 2 investors are named for Corindus Vascular Robotics, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$25 M of $25 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David W. Long · Executive Officer
  • Mark J. Toland · Executive Officer, Director
  • Campbell D. Rogers · Director
  • Douglas L. Braunstein · Director
  • James R. Tobin · Director
  • Jeffrey C. Lightcap · Director
  • Jeffrey G. Gold · Director
  • Louis A. Cannon · Director
  • Nthan R. Harrington · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David W. Long, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 28, 2018. Read the notice at the SEC.

equity, optionsSEC
Mar 2017$45 MNo. 2$10 to $50 million

Corindus Vascular Robotics, Inc.: Raise no. 2, Mar 2017

Investors in this round

16 investors had bought by the notice of Mar 29, 2017: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 2 investors are named for Corindus Vascular Robotics, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$45 M of $45 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David W. Long · Executive Officer
  • Mark J. Toland · Executive Officer, Director
  • Stephen J. Lemaster · Executive Officer
  • Campbell D. Rogers · Director
  • Gerard G. Winkels · Director
  • Jeffrey C. Lightcap · Director
  • Jeffrey G. Gold · Director
  • Louis A. Cannon · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David W. Long, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 29, 2017. Read the notice at the SEC.

equitySEC
Sep 2014$27 MNo. 1$10 to $50 million

Corindus Vascular Robotics, Inc.: Raise no. 1, Sep 2014

Investors in this round

15 investors had bought by the notice of Sep 23, 2014: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 2 investors are named for Corindus Vascular Robotics, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$27 M of $27 M offered
Smallest investment taken
$100,000
What was sold
equity
Exemption claimed
  • Rule 506(c): may be advertised publicly; every buyer must be a verified accredited investor
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$1,000,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Nevada

People named in the notice

  • David M Handler · Executive Officer, Director
  • David W Long · Executive Officer
  • David C White · Director
  • Gerard C Winkels · Director
  • Hillel C Bachrach · Director
  • Jeffrey C Gold · Director
  • Jeffrey C Lightcap · Director · Chairman
  • Michael C Mashaal · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Cowen and Company, LLC (CRD 7616) · New York, New YorkSold in MA, NJ, NY, VA
  • Stifel, Nicolaus & Company, Incorporated (CRD 0793) · San Francisco, CaliforniaSold in MA, NJ, NY, VA

Signed by /s/ David M. Handler, Chief Executive Officer. Source: SEC Form D, newest notice filed Sep 23, 2014. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Corindus Vascular Robotics, Inc. chose not to state its revenue in its newest notice of a funding round (Mar 2019).

    SEC Form D · Mar 2019

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Mar 2019

That is all the official record says: Corindus Vascular Robotics, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

2 named in official filings. Open an investor to see everything it has backed.

Investors in Corindus Vascular Robotics, Inc.
InvestorKindAmountRoundRoleSource
HEC Management GP LLCFund or asset managernot statednot statedHeld Series A preferred stock, 10% owner (Form 3, 2018)SEC Form 3
Hudson Executive Capital LPFund or asset managernot statednot statedHeld Series A preferred stock, 10% owner (Form 3, 2018)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 16 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Corindus Vascular Robotics, Inc.
NameRoleNamed in
David W. LongExecutive officerMar 2019
Douglas R. TeanyExecutive officerMar 2019
Mark J. TolandExecutive officerMar 2019
Stephen J. LemasterExecutive officerMar 2017
David M HandlerExecutive officerSep 2014
David W LongExecutive officerSep 2014
Campbell D. RogersDirectorMar 2019
Douglas L. BraunsteinDirectorMar 2019
James R. TobinDirectorMar 2019
Jeffrey C. LightcapDirectorMar 2019
Jeffrey G. GoldDirectorMar 2019
Louis A. CannonDirectorMar 2019
Mark J. TolandDirectorMar 2019
Nathan R. HarringtonDirectorMar 2019
Nthan R. HarringtonDirectorMar 2018
Gerard G. WinkelsDirectorMar 2017
David C WhiteDirectorSep 2014
David M HandlerDirectorSep 2014
Gerard C WinkelsDirectorSep 2014
Hillel C BachrachDirectorSep 2014
Jeffrey C GoldDirectorSep 2014
Jeffrey C LightcapChairmanSep 2014
Michael C MashaalDirectorSep 2014